Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.
Zhang Y, Xu M, Yuan J, Hu Z, Jiang J, Huang J, Wang B, Shen J, Long M, Fan Y, Montone KT, Tanyi JL, Tavana O, Chan HM, Hu X, Zhang L.
Zhang Y, et al. Among authors: hu z.
bioRxiv [Preprint]. 2024 May 21:2024.05.21.595159. doi: 10.1101/2024.05.21.595159.
bioRxiv. 2024.
PMID: 38826355
Free PMC article.
Preprint.